Related references
Note: Only part of the references are listed.TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model
F. J. Cubero et al.
CELL DEATH AND DIFFERENTIATION (2013)
Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium
Filip Van Hauwermeiren et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Obesity, inflammation, and liver cancer
Beicheng Sun et al.
JOURNAL OF HEPATOLOGY (2012)
Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury
Christian Liedtke et al.
GASTROENTEROLOGY (2011)
The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation
Marion C. Bonnet et al.
IMMUNITY (2011)
TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation
Francoise Meylan et al.
IMMUNOLOGICAL REVIEWS (2011)
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways
Jorn Markus Schattenberg et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
Patrick-Simon Welz et al.
NATURE (2011)
Functional complementation between FADD and RIP1 in embryos and lymphocytes
Haibing Zhang et al.
NATURE (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
Tom Luedde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination
Conor Mc Guire et al.
JOURNAL OF IMMUNOLOGY (2010)
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Johannes Haybaeck et al.
CANCER CELL (2009)
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
Naiara Beraza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
Mohamed IF Shariff et al.
Expert Review of Gastroenterology & Hepatology (2009)
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Manolis Pasparakis
NATURE REVIEWS IMMUNOLOGY (2009)
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development
Anne Grosse-Wilde et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
NF-kappa B signaling, liver disease and hepatoprotective agents
B. Sun et al.
ONCOGENE (2008)
IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver
Tom Luedde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma
Tom Luedde et al.
CANCER CELL (2007)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis
ZY Hao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
NEMO/IKKγ-deficient mice model incontinentia pigmenti
M Schmidt-Supprian et al.
MOLECULAR CELL (2000)
Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
C Makris et al.
MOLECULAR CELL (2000)
Share Paper
